The Management of Cardiovascular Risk through Epigenetic Biomarkers
Epigenetic sciences study heritable changes in gene expression not related to changes in the genomic DNA sequence. The most important epigenetic mechanisms are DNA methylation, posttranslational histone modification, and gene regulation by noncoding RNAs, such as microRNAs (miRNAs) and long noncodin...
Main Authors: | Laurent Metzinger, Stefano de Franciscis, Raffaele Serra |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2017/9158572 |
Similar Items
-
Roles and Clinical Applications of Biomarkers in Cardiovascular Disease
by: Stefano de Franciscis, et al.
Published: (2016-01-01) -
Roles and Clinical Applications of Biomarkers in Cardiovascular Disease 2017
by: Raffaele Serra, et al.
Published: (2017-01-01) -
The Discovery of Novel Genomic, Transcriptomic, and Proteomic Biomarkers in Cardiovascular and Peripheral Vascular Disease: The State of the Art
by: Stefano de Franciscis, et al.
Published: (2016-01-01) -
Epigenetic Biomarkers in Cardiovascular Diseases
by: Carolina Soler-Botija, et al.
Published: (2019-10-01) -
The Non-coding MicroRNA-223 is a Promising Biomarker of Chronic Kidney Disease
by: Valérie Metzinger-Le Meuth, et al.
Published: (2021-07-01)